Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

EPA/AB stock hub

EPA/AB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

EPA/ABis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
70M
Euronext Paris
Market data

Price

Recent price action with selectable time range.

EPA/ABEPA/AB
—
Loading chart…
In the news

Latest news · EPA/AB

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROICn/a
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All EPA/AB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
173
Groups with data
11
Currency
EUR
Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
France
Country code
FR
Employees
36
Employees Change
-3%
Employees Change Percent
-7.69
Enterprise value
EUR 84M
Exchange
Euronext Paris
Financial currency
EUR
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
FR0010557264
Last refreshed
2026-05-10
Market cap
EUR 70M
Price
EUR 0.96
Price currency
EUR
Rev Per Employee
28,527.78x
Sector
Healthcare
Sic
2834
Symbol
epa/AB
Website
https://www.ab-science.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-12.21%
EV Earnings
-9.84x
EV/FCF
-11.86x
EV/Sales
81.8x
FCF yield
-10.12%
P/B ratio
-2.56x
P/S ratio
68.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

13
MetricValue
Gross margin
90.75%
Gross Profit
EUR 932,000
Gross Profit Growth
-25.32%
Gross Profit Growth Q
-67.67%
Gross Profit Growth3 Y
16.66%
Gross Profit Growth5 Y
0.11%
Net Income
EUR -8.5M
Net Income Growth Years
8%
Pretax Margin
-831.45%
Profit Per Employee
EUR -237,194
ROA
-14.79
Roa5y
-33.31
ROCE
-184.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr10y
-24.86%
Cagr15y
-13.57%
Cagr1y
-34.78%
Cagr3y
-45.48%
Cagr5y
-42.07%
EPS Growth Years
8
Revenue Growth
-5.08x
Revenue Growth Q
-8.04x
Revenue Growth Years
2x
Revenue Growth3 Y
1.92x
Revenue Growth5 Y
1.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Asset Turnover
EUR 0.05
Assets
EUR 21.2M
Cash
EUR 5M
Current Assets
EUR 12.3M
Current Liabilities
EUR 18.4M
Debt
EUR 19.1M
Debt FCF
EUR -2.69
Equity
EUR -27.3M
Interest Coverage
-4.57
Liabilities
EUR 48.5M
Long Term Assets
EUR 8.9M
Long Term Liabilities
EUR 30.2M
Net Cash
EUR -14M
Net Cash By Market Cap
EUR -20.08
Tangible Book Value
EUR -28.4M
Tangible Book Value Per Share
EUR -0.43
WACC
9.46

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.67
Inventory Turnover
0.44
Net Working Capital
EUR -8.2M
Quick ratio
0.64
Working Capital
EUR -6.1M
Working Capital Turnover
EUR -0.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-9.43%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-94.26%
1Y total return
-34.76%
200-day SMA
1.27
3Y total return
-83.8%
50-day SMA
1.19
50-day SMA vs 200-day SMA
50under200
5Y total return
-93.48%
All Time High
23
All Time High Change
-95.83%
All Time High Date
2012-10-31
All Time Low
0.77
All Time Low Change
24.55%
All Time Low Date
2024-11-25
ATR
0.04
Beta
1.18
Beta1y
0.63
Beta2y
0.48
Ch YTD
-37.57
High
0.97
High52
1.73
High52 Date
2025-07-29
High52ch
-44.57%
Low
0.95
Low52
0.95
Low52 Date
2026-05-08
Low52ch
0.95%
Ma50ch
-19.34%
Price vs 200-day SMA
-24.31%
RSI
21.79
RSI Monthly
36.68
RSI Weekly
29.53
Sharpe ratio
-0.61x
Sortino ratio
-0.86
Total Return
-9.43%
Tr YTD
-37.57
Tr15y
-88.78%
Tr1m
-18.17%
Tr1w
-4.1%
Tr3m
-30.51%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR -5.2M
Operating margin
-509.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
27,853,443%
Net Borrowing
-1,825,000
Shares Insiders
31.11%
Shares Institutions
0%
Shares Out
72,947,472
Shares Qo Q
6.32%
Shares Yo Y
9.43%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

50
MetricValue
Adjusted FCF
EUR -10M
Average Volume
230,686.45x
Bv Per Share
-0.41
CAPEX
EUR -203,000
Ch10y
-94.26
Ch15y
-88.78
Ch1m
-18.17
Ch1w
-4.1
Ch1y
-34.76
Ch3m
-30.51
Ch3y
-83.8
Ch5y
-93.48
Ch6m
-17.04
Change
-0.83%
Change From Open
-0.83
Close
0.97
Days Gap
0
Depreciation Amortization
523,000
Dollar Volume
204,027.3
Earnings Date
2026-05-13
EBIT
EUR -5.2M
EBITDA
EUR -4.7M
EPS
EUR -0.15
F Score
2
FCF
EUR -7.1M
FCF EV Yield
-8.43x
FCF Per Share
EUR -0.1
Financing CF
2,967,000
Fiscal Year End
December
Founded
2,001
Investing CF
-189,000
Is Primary Listing
1
Last Earnings Date
2025-09-30
Last Report Date
2025-06-30
Ma150
1.26
Ma150ch
-23.77%
Ma20
1.12
Ma20ch
-14.38%
Net CF
-4,104,000
Next Earnings Date
2026-05-13
Open
0.97
Position In Range
40.91
Ppne
1,092,000
Price Date
2026-05-08
Relative Volume
0.93x
Revenue
1,027,000x
SBC By Revenue
287.73x
Share Based Comp
2,955,000
Tr6m
-17.04%
Volume
212,750
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does EPA/AB pay a dividend?

Capital-return profile for this ticker.

Performance

EPA/AB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-34.8%
S&P 500 1Y: n/a
3Y total return
-83.8%
S&P 500 3Y: n/a
5Y total return
-93.5%
S&P 500 5Y: n/a
10Y total return
-94.3%
S&P 500 10Y: n/a
Ownership

Who owns EPA/AB?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.0%
Share of float held by funds and institutions
Insider ownership
+31.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+9.4%
Negative means the company is buying back shares.
Technical

EPA/AB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
21.8
Below 30: short-term oversold
Price vs 200-day MA
-24.3%
50/200-day relationship not available
Beta (5Y)
1.18
Moves roughly with the market
Sharpe ratio
-0.61
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About EPA/AB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current epa/AB stock rating?

epa/AB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full epa/AB analysis?

The full report lives at /stocks/epa/AB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for epa/AB?

The latest report frames epa/AB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the epa/AB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.